Sprinklr (CXM) Reports Q3 Earnings: What Key Metrics Have to Say

For the quarter ended October 2025, Sprinklr (CXM) reported revenue of $219.07 million, up 9.2% over the same period last year. EPS came in at $0.12, compared to $0.10 in the year-ago quarter.The reported revenue represents a surprise of +4.54% over the Zacks Consensus Estimate of $209.55 million. With the consensus EPS estimate being $0.09, the EPS surprise was +33.33%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Sprinklr performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Gross Margin - Subscription: 76% versus 76.5% estimated by two analysts on average.Revenue- Subscription: $190.3 million versus the two-analyst average estimate of $186.49 million. The reported number represents a year-over-year change of +5.4%.Revenue- Professional services: $28.77 million versus $23.07 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +43.5% change.View all Key Company Metrics for Sprinklr here>>>Shares of Sprinklr have returned +2.9% over the past month versus the Zacks S&P 500 composite's +0.1% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Sprinklr, Inc. (CXM): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks